SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Introgen Therapeutics
An SI Board Since February 2004
Posts SubjectMarks Bans Symbol
802 21 0 INGN
Emcee:  tuck Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromPosted
427Thanks for holding the fort in my absence-g- Yikes, Bernard 4 buks?.argh..Mamzeta19619/15/2005
426<i> Watching to see if it can hold the 5.40 level, where I would buy some,Jibacoa9/15/2005
425[INGN 007 preclinical results] >>AUSTIN, Texas, Sept. 13 /PRNewswire-Firstuck9/13/2005
424This press release at 2PM was what made the stock change directions today and leJibacoa9/12/2005
423More selling by aventis...42K shares secinfo.comzeta19619/9/2005
422I think there's an autosell order with key word:mda7-g-zeta19619/8/2005
421Another press release, but it isn't helping the stock price which seems readJibacoa9/8/2005
420Aventis sold 165K this adds to 60K sold on 9/1/05, leaving them with approx 2milzeta19619/8/2005
419<INGN 241 Phase 1> Clinical and local biological effects of an intratumorazeta19619/8/2005
418Identification of Novel p53 Target Genes in Ionizing Radiation Response. Jen KYzeta19619/8/2005
417An expression signature for p53 status in human breast cancer predicts mutation zeta19619/8/2005
416Old news?..nah, they're saying it in Greek this time?-g- It's the Decemzeta19619/7/2005
415All old news except for the VEGF angle. Perhaps the market interprets this to mtuck9/7/2005
414The new press release is not helping the stock price.<g> <b>AntitumJibacoa9/7/2005
413<i> Would have been nice if they had put some actual new data in the PR. AJibacoa9/6/2005
412>>042 MDA7/IL-24: NOVEL MELANOCYTE-DERIVED CYTOKINE, EXHIBITING IMMUNE ANDtuck9/6/2005
411Would have been nice if they had put some actual new data in the PR. A bit fluftuck9/6/2005
410<b> New Data for Introgen Therapeutics' INGN 241 Show Promise in PreveJibacoa9/6/2005
409<IMCL thread>..ha, ha..gotta' keep an eye on them..I've already swzeta19618/23/2005
408Getting back on INGN, the stock is moving up on low volume (only 58,642 so far) Jibacoa8/22/2005
407O.T. For a while I thought I was on the IMCL thread.<g> IMCL is still trJibacoa8/22/2005
406EDITORIAL on Erbitux h/n studies JCO August 20, 2005 [note that this author haszeta19618/18/2005
405Second Erbitux P2 head and neck, JCO, August 20, 2005 Phase II Multicenter Studzeta19618/18/2005
404Erbitux P2 published study in JCO August 20, 2005 [one of 2] Phase II Multicenzeta19618/18/2005
403O.T. Ian: If you want to see the daily list you can do it at this link: nasdaqtJibacoa8/11/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News